Melbourne, Australia

Clinuvel Pharmaceuticals Limited


USPTO Granted Patents = 8

% Expired Patents = 12.5



Forward Citations = 6

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Michael John Kleinig (4 out of 6 patents)

silverMedal Thomas R Tice (3 out of 49 patents)

bronzeMedal Jay K Staas (3 out of 16 patents)

4.  Philippe Wolgen (3 out of 3 patents)

5.  Berno I Pettersson, Jr (1 out of 3 patents)

6.  Stuart Michael Humphrey (1 out of 1 patent)

7.  Kenneth B Kirby (1 out of 4 patents)

8.  Thomas A Luger (5 patents)

9.  Karin Loser (1 patent)

10.  Berno I Pettersson (0 patent)

11.  Jr Berno I Pettersson (0 patent)


8 patents:

Company Overview
Clinuvel Pharmaceuticals Limited is a global biopharmaceutical company focused on developing and commercializing treatments for patients with a range of severe genetic and skin disorders. The company's lead product, SCENESSE, is approved in Europe and Australia for the treatment of EPP, a rare genetic disorder causing severe phototoxic reactions to sunlight. Clinuvel's mission is to improve the quality of life for patients suffering from life-threatening and debilitating disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#36 in Melbourne

#499 in Australia

Melbourne, AU
Melbourne, Australia
Forward Citations = 6

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Clinuvel Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/clinuvel-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…